In general, the pluripotency of embryonic stem (ES) cells, including
human pluripotent stem cells and induced pluripotent stem (iPS) cells,
can be maintained by replacing fibroblast growth factor (FGF-2)-
containing medium regularly to prevent spontaneous differentiation